


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 4 Jan 2008
IMS Health Announces Restructuring Actions to Improve Operating Efficiencies, Address Client Priorities
IMS Health Announces Restructuring Actions to Improve Operating Efficiencies, Address Client Priorities
HSMN NewsFeed - 4 Jan 2008
Trellis Bioscience Appoints John Wulf as EVP, Business Operations and Chief Business Officer
Trellis Bioscience Appoints John Wulf as EVP, Business Operations and Chief Business Officer
HSMN NewsFeed - 4 Jan 2008
ImaRx Provides Update on TUCSON Phase I/II Clinical Trial in Acute Ischemic Stroke
ImaRx Provides Update on TUCSON Phase I/II Clinical Trial in Acute Ischemic Stroke
HSMN NewsFeed - 3 Jan 2008
Intercept Pharmaceuticals Names Dr. Luciano Adorini Chief Scientific Officer
Intercept Pharmaceuticals Names Dr. Luciano Adorini Chief Scientific Officer
HSMN NewsFeed - 3 Jan 2008
EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
HSMN NewsFeed - 3 Jan 2008
Akela Pharma licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Canada
Akela Pharma licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Canada
HSMN NewsFeed - 2 Jan 2008
Biovail Announces Supply Agreement for Commercialization of Extended-Release Tramadol
Biovail Announces Supply Agreement for Commercialization of Extended-Release Tramadol
HSMN NewsFeed - 31 Dec 2007
Salix Pharmaceuticals Announces Submission of Granulated Mesalamine New Drug Application
Salix Pharmaceuticals Announces Submission of Granulated Mesalamine New Drug Application
HSMN NewsFeed - 31 Dec 2007
OXiGENE Reports Positive Results in Phase 2 Study of ZYBRESTAT(TM) in Platinum-Resistant Ovarian Cancer
OXiGENE Reports Positive Results in Phase 2 Study of ZYBRESTAT(TM) in Platinum-Resistant Ovarian Cancer
HSMN NewsFeed - 28 Dec 2007
Encysive Pharmaceuticals Announces Patent Infringement Lawsuit Against Barr Laboratories
Encysive Pharmaceuticals Announces Patent Infringement Lawsuit Against Barr Laboratories
HSMN NewsFeed - 28 Dec 2007
Perrigo Announces FDA Approval for Over-The-Counter Cetirizine Hydrochloride Tablets
Perrigo Announces FDA Approval for Over-The-Counter Cetirizine Hydrochloride Tablets
HSMN NewsFeed - 28 Dec 2007
Transition Therapeutics Announces Appointment of Vice-President of Business Development
Transition Therapeutics Announces Appointment of Vice-President of Business Development
HSMN NewsFeed - 27 Dec 2007
Theravance Receives Notice of Possible Telavancin Review by FDA Advisory Committee
Theravance Receives Notice of Possible Telavancin Review by FDA Advisory Committee
HSMN NewsFeed - 27 Dec 2007
Endo Pharmaceuticals to Develop and Commercialize Alexza's AZ-003 Staccato(R) Inhaled Fentanyl Product
Endo Pharmaceuticals to Develop and Commercialize Alexza's AZ-003 Staccato(R) Inhaled Fentanyl Product
HSMN NewsFeed - 27 Dec 2007
Manhattan Pharmaceuticals Names Mary C. Spellman, M.D. as Head of Dermatology and Drug Development
Manhattan Pharmaceuticals Names Mary C. Spellman, M.D. as Head of Dermatology and Drug Development
HSMN NewsFeed - 27 Dec 2007
U.S. District Court Decision About Eisai's Legal Action Over Aricept ODT(R) ANDA Filing
U.S. District Court Decision About Eisai's Legal Action Over Aricept ODT(R) ANDA Filing
HSMN NewsFeed - 26 Dec 2007
Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules
Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules
HSMN NewsFeed - 24 Dec 2007
Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
HSMN NewsFeed - 21 Dec 2007
GE Healthcare Announces Expansion of Nuclear Cardiology Portfolio for Medical Diagnostics Business
GE Healthcare Announces Expansion of Nuclear Cardiology Portfolio for Medical Diagnostics Business
HSMN NewsFeed - 21 Dec 2007
Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
HSMN NewsFeed - 21 Dec 2007
ISENTRESS(R) (raltegravir) from MSD, First Integrase Inhibitor, Approved by the European Union Commission
ISENTRESS(R) (raltegravir) from MSD, First Integrase Inhibitor, Approved by the European Union Commission
HSMN NewsFeed - 21 Dec 2007
Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neurosciences, Inc.
Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neurosciences, Inc.
HSMN NewsFeed - 20 Dec 2007
DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA
DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA
HSMN NewsFeed - 20 Dec 2007
Abbott's HUMIRA(R) Approved in the European Union for Treatment of Moderate-to-Severe Plaque Psoriasis
Abbott's HUMIRA(R) Approved in the European Union for Treatment of Moderate-to-Severe Plaque Psoriasis
HSMN NewsFeed - 20 Dec 2007
Marketing of Viadur(R) (leuprolide acetate implant) to Phase Out by April 2008
Marketing of Viadur(R) (leuprolide acetate implant) to Phase Out by April 2008
HSMN NewsFeed - 20 Dec 2007
Valeant Pharmaceuticals Sells Hep-C Drug Infergen(R) to Three Rivers Pharmaceuticals(R), LLC for $91 Million
Valeant Pharmaceuticals Sells Hep-C Drug Infergen(R) to Three Rivers Pharmaceuticals(R), LLC for $91 Million
HSMN NewsFeed - 20 Dec 2007
Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
HSMN NewsFeed - 19 Dec 2007
Curis, Inc. Announces Appointment of Stephen K. Carter, M.D. to its Board of Directors
Curis, Inc. Announces Appointment of Stephen K. Carter, M.D. to its Board of Directors
HSMN NewsFeed - 19 Dec 2007
Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer
Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer
HSMN NewsFeed - 18 Dec 2007
Pharmos Corporation Announces President & COO Alan L. Rubino to Leave Company
Pharmos Corporation Announces President & COO Alan L. Rubino to Leave Company
HSMN NewsFeed - 18 Dec 2007
Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
HSMN NewsFeed - 18 Dec 2007
Forward Ventures Joins Series A Syndicate for Newly Formed Altair Therapeutics
Forward Ventures Joins Series A Syndicate for Newly Formed Altair Therapeutics
HSMN NewsFeed - 17 Dec 2007
Lilly and BioMS Medical Announce Global Licensing and Development Agreement
Lilly and BioMS Medical Announce Global Licensing and Development Agreement
HSMN NewsFeed - 17 Dec 2007
Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation
Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation
HSMN NewsFeed - 17 Dec 2007
GlaxoSmithKline Receives FDA 'Complete Response' Letter for Cervical Cancer Vaccine
GlaxoSmithKline Receives FDA 'Complete Response' Letter for Cervical Cancer Vaccine
HSMN NewsFeed - 17 Dec 2007
Immusol Changes Name to ItherX, Names Jeffrey F. McKelvy President and Chief Executive Officer
Immusol Changes Name to ItherX, Names Jeffrey F. McKelvy President and Chief Executive Officer
HSMN NewsFeed - 17 Dec 2007
Endo Announces Positive Results From Interim Analysis of RAPINYL(TM) Phase III Clinical Trial
Endo Announces Positive Results From Interim Analysis of RAPINYL(TM) Phase III Clinical Trial
HSMN NewsFeed - 17 Dec 2007
Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
HSMN NewsFeed - 14 Dec 2007
Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
HSMN NewsFeed - 14 Dec 2007
Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
HSMN NewsFeed - 14 Dec 2007
Bradley Pharmaceuticals Launches Veregen(TM) (sinecatechins) Ointment, 15%
Bradley Pharmaceuticals Launches Veregen(TM) (sinecatechins) Ointment, 15%
HSMN NewsFeed - 14 Dec 2007
OSI Pharmaceuticals Announces Launch Date of Tarceva(R) (erlotinib) in Japan
OSI Pharmaceuticals Announces Launch Date of Tarceva(R) (erlotinib) in Japan
HSMN NewsFeed - 14 Dec 2007
Isis Announces Appointment of B. Lynne Parshall as Chief Operating Officer
Isis Announces Appointment of B. Lynne Parshall as Chief Operating Officer
HSMN NewsFeed - 13 Dec 2007
Forest Laboratories Receives Notification of ANDA Filings for Generic Equivalents of Namenda(R)
Forest Laboratories Receives Notification of ANDA Filings for Generic Equivalents of Namenda(R)
HSMN NewsFeed - 13 Dec 2007
Iloperidone Phase III Clinical Data Demonstrate Efficacy and Favorable Safety and Tolerability Profile
Iloperidone Phase III Clinical Data Demonstrate Efficacy and Favorable Safety and Tolerability Profile
HSMN NewsFeed - 13 Dec 2007
Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
HSMN NewsFeed - 13 Dec 2007
Neurologix Gene Therapy Approach to Parkinson's Disease Granted Fast Track Designation From FDA
Neurologix Gene Therapy Approach to Parkinson's Disease Granted Fast Track Designation From FDA
HSMN NewsFeed - 13 Dec 2007
Puricase(R) (pegloticase) Meets Pre-Specified Primary Efficacy Endpoint in Two Replicate Phase 3 Studies
Puricase(R) (pegloticase) Meets Pre-Specified Primary Efficacy Endpoint in Two Replicate Phase 3 Studies
HSMN NewsFeed - 13 Dec 2007
Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease
Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease
HSMN NewsFeed - 12 Dec 2007
Merck Announces Voluntary Recall of Certain Lots of PEDVAXHIB(R) and COMVAX(R)
Merck Announces Voluntary Recall of Certain Lots of PEDVAXHIB(R) and COMVAX(R)
HSMN NewsFeed - 12 Dec 2007
New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo
New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo
HSMN NewsFeed - 12 Dec 2007
INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia
INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia
HSMN NewsFeed - 12 Dec 2007
Once-Daily Exjade(R) Shown to Remove Toxic Iron From the Heart and Liver, According to Data Presented at ASH
Once-Daily Exjade(R) Shown to Remove Toxic Iron From the Heart and Liver, According to Data Presented at ASH
HSMN NewsFeed - 11 Dec 2007
FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation
FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation
HSMN NewsFeed - 11 Dec 2007
EntreMed Announces FDA Acceptance of IND Application for Panzem(R) in Rheumatoid Arthritis
EntreMed Announces FDA Acceptance of IND Application for Panzem(R) in Rheumatoid Arthritis
HSMN NewsFeed - 11 Dec 2007
OREXIGEN(TM) Therapeutics Initiates Fourth Phase III Trial for Contrave(TM) to Treat Obesity
OREXIGEN(TM) Therapeutics Initiates Fourth Phase III Trial for Contrave(TM) to Treat Obesity
HSMN NewsFeed - 11 Dec 2007
Artes Medical Names Karon J. Morell as Vice President, Regulatory and Quality Affairs
Artes Medical Names Karon J. Morell as Vice President, Regulatory and Quality Affairs
HSMN NewsFeed - 11 Dec 2007
Synthetic Blood Announces Progress with Oxycyte Program in Traumatic Brain Injury
Synthetic Blood Announces Progress with Oxycyte Program in Traumatic Brain Injury
HSMN NewsFeed - 11 Dec 2007
New Phase III Trial Shows Positive Outcome of lacosamide in Patients with Diabetic Neuropathic Pain
New Phase III Trial Shows Positive Outcome of lacosamide in Patients with Diabetic Neuropathic Pain
HSMN NewsFeed - 10 Dec 2007
Pivotal Phase 3 NPLATE(TM) Study in Non-Splenectomized Patients Met Primary Endpoints
Pivotal Phase 3 NPLATE(TM) Study in Non-Splenectomized Patients Met Primary Endpoints
HSMN NewsFeed - 10 Dec 2007
Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
HSMN NewsFeed - 10 Dec 2007
Fundamental Applied Biology, Inc. Completes $21 Million Series B Financing
Fundamental Applied Biology, Inc. Completes $21 Million Series B Financing
HSMN NewsFeed - 8 Dec 2007
Pivotal Phase 3 Romiplostim Study in Splenectomized Patients Meets Primary Endpoints
Pivotal Phase 3 Romiplostim Study in Splenectomized Patients Meets Primary Endpoints
HSMN NewsFeed - 7 Dec 2007
DOR BioPharma Announces Results of orBec(R) End of Review Conference With the FDA
DOR BioPharma Announces Results of orBec(R) End of Review Conference With the FDA
HSMN NewsFeed - 7 Dec 2007
Amgen in Discussions with FDA to Update U.S. Prescribing Information for ESAs
Amgen in Discussions with FDA to Update U.S. Prescribing Information for ESAs
HSMN NewsFeed - 6 Dec 2007
Somaxon Pharmaceuticals Names David F. Hale Executive Chairman and Interim Chief Executive Officer
Somaxon Pharmaceuticals Names David F. Hale Executive Chairman and Interim Chief Executive Officer
HSMN NewsFeed - 6 Dec 2007
Onset Therapeutics Announces FDA Submission for Novel Product for Topical Treatment of Genital Warts
Onset Therapeutics Announces FDA Submission for Novel Product for Topical Treatment of Genital Warts
HSMN NewsFeed - 6 Dec 2007
Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
HSMN NewsFeed - 6 Dec 2007
Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting
Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting
HSMN NewsFeed - 5 Dec 2007
Theravance Announces Positive Topline Results In Phase 3 Telavancin Hospital-Acquired Pneumonia Program
Theravance Announces Positive Topline Results In Phase 3 Telavancin Hospital-Acquired Pneumonia Program
HSMN NewsFeed - 5 Dec 2007
Vectibix(R) Approved in the European Union for the Treatment of Metastatic Colorectal Cancer
Vectibix(R) Approved in the European Union for the Treatment of Metastatic Colorectal Cancer
HSMN NewsFeed - 5 Dec 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Norvasc(R)
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Norvasc(R)
HSMN NewsFeed - 5 Dec 2007
Edward J. Schutter Appointed to President and Chief Operating Officer of Sciele Pharma, Inc.
Edward J. Schutter Appointed to President and Chief Operating Officer of Sciele Pharma, Inc.
HSMN NewsFeed - 5 Dec 2007
New Data Reinforces the Superiority of Escitalopram Over Duloxetine for Acute Treatment of Depression
New Data Reinforces the Superiority of Escitalopram Over Duloxetine for Acute Treatment of Depression
HSMN NewsFeed - 4 Dec 2007
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results
HSMN NewsFeed - 4 Dec 2007
Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit
Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit
HSMN NewsFeed - 4 Dec 2007
AVAX Technologies Appoints Dr. Francois Martelet as President and Chief Executive Officer
AVAX Technologies Appoints Dr. Francois Martelet as President and Chief Executive Officer
HSMN NewsFeed - 4 Dec 2007
Oracle Healthcare Acquisition Corp. and Precision Therapeutics Announce Definitive Merger Agreement
Oracle Healthcare Acquisition Corp. and Precision Therapeutics Announce Definitive Merger Agreement
HSMN NewsFeed - 4 Dec 2007
VistaGen Names Agustin de la Calle, Ph.D. as Vice President, Business Development
VistaGen Names Agustin de la Calle, Ph.D. as Vice President, Business Development
HSMN NewsFeed - 4 Dec 2007
Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets
Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets
HSMN NewsFeed - 4 Dec 2007
PregLem SA Announces CHF 36 Million Series B Funding and New Licencing Agreement With HRA Pharma
PregLem SA Announces CHF 36 Million Series B Funding and New Licencing Agreement With HRA Pharma
HSMN NewsFeed - 3 Dec 2007
Regulus Therapeutics Appoints Kleanthis G. Xanthopoulos, Ph.D. as President and Chief Executive Officer
Regulus Therapeutics Appoints Kleanthis G. Xanthopoulos, Ph.D. as President and Chief Executive Officer
HSMN NewsFeed - 2 Dec 2007
FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension
FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension
HSMN NewsFeed - 30 Nov 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R)
Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R)
HSMN NewsFeed - 30 Nov 2007
FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
HSMN NewsFeed - 30 Nov 2007
Pfizer Inc Commences Tender Offer for All Outstanding Shares of Coley Pharmaceutical Group, Inc.
Pfizer Inc Commences Tender Offer for All Outstanding Shares of Coley Pharmaceutical Group, Inc.
HSMN NewsFeed - 29 Nov 2007
Amneal Receives FDA Approval for Bethanechol Chloride Tablets, USP Using New Expedited FDA Approval Process
Amneal Receives FDA Approval for Bethanechol Chloride Tablets, USP Using New Expedited FDA Approval Process
HSMN NewsFeed - 29 Nov 2007
Sagent Pharmaceuticals Launches Full-Line of Prefilled 6 mg and 12 mg Adenosine Syringes
Sagent Pharmaceuticals Launches Full-Line of Prefilled 6 mg and 12 mg Adenosine Syringes
HSMN NewsFeed - 29 Nov 2007
Kythera Biopharmaceuticals Appoints Amgen Veteran as Chief Financial Officer
Kythera Biopharmaceuticals Appoints Amgen Veteran as Chief Financial Officer
HSMN NewsFeed - 29 Nov 2007
First European Patient Treated in CABERNET Trial With Novel Treatment for Wet AMD
First European Patient Treated in CABERNET Trial With Novel Treatment for Wet AMD
HSMN NewsFeed - 29 Nov 2007
UCB Announces FDA Filing for lacosamide in the Treatment of Diabetic Neuropathic Pain
UCB Announces FDA Filing for lacosamide in the Treatment of Diabetic Neuropathic Pain
HSMN NewsFeed - 29 Nov 2007
UCB Announces FDA Filing for lacosamide in the Treatment of Partial Onset Seizures in Adults with Epilepsy
UCB Announces FDA Filing for lacosamide in the Treatment of Partial Onset Seizures in Adults with Epilepsy
HSMN NewsFeed - 28 Nov 2007
Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
HSMN NewsFeed - 27 Nov 2007
Neuromed Appoints Jeffrey Arcara and Gene Wright to Senior Management Team
Neuromed Appoints Jeffrey Arcara and Gene Wright to Senior Management Team
HSMN NewsFeed - 27 Nov 2007
ImmunoGen, Inc. Hires John Tagliamonte as Vice President, Business Development
ImmunoGen, Inc. Hires John Tagliamonte as Vice President, Business Development
HSMN NewsFeed - 27 Nov 2007
Valeant Pharmaceuticals Completes Enrollment of Second Pivotal Phase 3 Trial for Epilepsy Drug Retigabine
Valeant Pharmaceuticals Completes Enrollment of Second Pivotal Phase 3 Trial for Epilepsy Drug Retigabine
HSMN NewsFeed - 27 Nov 2007
Clarus Therapeutics Announces Completion of $8 Million Series C Financing Round
Clarus Therapeutics Announces Completion of $8 Million Series C Financing Round
HSMN NewsFeed - 27 Nov 2007
Introgen's ADVEXIN Advances as Marketing Authorization Application is Accepted for Review in Europe
Introgen's ADVEXIN Advances as Marketing Authorization Application is Accepted for Review in Europe
HSMN NewsFeed - 27 Nov 2007
Gendux Announces Acceptance of Its ADVEXIN Marketing Authorization Application for Review by the EMEA
Gendux Announces Acceptance of Its ADVEXIN Marketing Authorization Application for Review by the EMEA
HSMN NewsFeed - 26 Nov 2007
Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales
Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales
HSMN NewsFeed - 26 Nov 2007
Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
HSMN NewsFeed - 26 Nov 2007
CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
HSMN NewsFeed - 26 Nov 2007
Beijing Med-Pharm Announces Exclusive Agreement to Market Enablex(R) in China
Beijing Med-Pharm Announces Exclusive Agreement to Market Enablex(R) in China
HSMN NewsFeed - 23 Nov 2007
Bristol-Myers Squibb and Pierre Fabre Provide Update On Vinflunine Development Status
Bristol-Myers Squibb and Pierre Fabre Provide Update On Vinflunine Development Status
HSMN NewsFeed - 23 Nov 2007
Orexo Completes the Acquisition of Biolipox, Appoints New CEO and Publishes a Prospectus
Orexo Completes the Acquisition of Biolipox, Appoints New CEO and Publishes a Prospectus
HSMN NewsFeed - 21 Nov 2007
Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
HSMN NewsFeed - 21 Nov 2007
Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
HSMN NewsFeed - 20 Nov 2007
Anika Therapeutics and Galderma Agree to Terminate License, Development and Supply Agreements
Anika Therapeutics and Galderma Agree to Terminate License, Development and Supply Agreements
HSMN NewsFeed - 20 Nov 2007
Alfacell Appoints Lawrence A. Kenyon Chief Operating Officer and Director
Alfacell Appoints Lawrence A. Kenyon Chief Operating Officer and Director
HSMN NewsFeed - 20 Nov 2007
Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
HSMN NewsFeed - 19 Nov 2007
Meyer Pharmaceuticals Acquires NF-kappaB Decoy Technology for Treatment of Inflammatory Disease
Meyer Pharmaceuticals Acquires NF-kappaB Decoy Technology for Treatment of Inflammatory Disease
HSMN NewsFeed - 19 Nov 2007
Industry Veteran Timothy Saxon Joins Tris Pharma as Vice President, Business Development
Industry Veteran Timothy Saxon Joins Tris Pharma as Vice President, Business Development
HSMN NewsFeed - 19 Nov 2007
Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntington's Disease Program
Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntington's Disease Program
HSMN NewsFeed - 19 Nov 2007
Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R)
Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R)
HSMN NewsFeed - 19 Nov 2007
Industry Veteran Timothy Saxon Joins Tris Pharma as Vice President, Business Development
Industry Veteran Timothy Saxon Joins Tris Pharma as Vice President, Business Development
HSMN NewsFeed - 19 Nov 2007
Covidien Signs Contrast Imaging Agent Agreement with MedAssets Supply Chain Systems
Covidien Signs Contrast Imaging Agent Agreement with MedAssets Supply Chain Systems
HSMN NewsFeed - 19 Nov 2007
Ceragenix and Dr. Reddy's Enter Into Distribution and Supply Agreement for EpiCeram(R)
Ceragenix and Dr. Reddy's Enter Into Distribution and Supply Agreement for EpiCeram(R)
HSMN NewsFeed - 19 Nov 2007
Sciele Signs Exclusive Agreement with Novo Nordisk to Market Prandin(R) and PrandiMet(R)
Sciele Signs Exclusive Agreement with Novo Nordisk to Market Prandin(R) and PrandiMet(R)
HSMN NewsFeed - 19 Nov 2007
Oculus Innovative Sciences Wins Federal Court Ruling in Intellectual Property Rights Litigation
Oculus Innovative Sciences Wins Federal Court Ruling in Intellectual Property Rights Litigation
HSMN NewsFeed - 16 Nov 2007
FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription
FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription
HSMN NewsFeed - 16 Nov 2007
Novis Pharmaceuticals Announces Hiring of Thomas E. Burke III as President and CEO
Novis Pharmaceuticals Announces Hiring of Thomas E. Burke III as President and CEO
HSMN NewsFeed - 16 Nov 2007
Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis
Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis
HSMN NewsFeed - 16 Nov 2007
Argos Therapeutics and Therakos, Inc. Enter Exclusive Agreement for Regulatory T Cell Technology
Argos Therapeutics and Therakos, Inc. Enter Exclusive Agreement for Regulatory T Cell Technology
HSMN NewsFeed - 16 Nov 2007
SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
HSMN NewsFeed - 16 Nov 2007
ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
HSMN NewsFeed - 16 Nov 2007
UCB to Appeal European Negative Opinion on CIMZIA(R) for the Treatment of Patients with Crohn's Disease
UCB to Appeal European Negative Opinion on CIMZIA(R) for the Treatment of Patients with Crohn's Disease
HSMN NewsFeed - 15 Nov 2007
Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension
Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension
HSMN NewsFeed - 15 Nov 2007
Endo and Penwest File Lawsuit Against IMPAX Laboratories Relating to OPANA(R) ER
Endo and Penwest File Lawsuit Against IMPAX Laboratories Relating to OPANA(R) ER
HSMN NewsFeed - 15 Nov 2007
High-price Vaccines Spark Four-fold Growth in Pediatric & Adolescent Vaccines Market
High-price Vaccines Spark Four-fold Growth in Pediatric & Adolescent Vaccines Market
HSMN NewsFeed - 15 Nov 2007
Getting Ready Corporation and Winston Laboratories, Inc. Announce Merger Agreement
Getting Ready Corporation and Winston Laboratories, Inc. Announce Merger Agreement
HSMN NewsFeed - 15 Nov 2007
Intranasal Therapeutics, Inc. Names Vice Presidents of Pharmaceutical Development and Commercial Development
Intranasal Therapeutics, Inc. Names Vice Presidents of Pharmaceutical Development and Commercial Development
HSMN NewsFeed - 15 Nov 2007
Novis Pharmaceuticals Announces Hiring of Thomas E. Burke III as President and CEO
Novis Pharmaceuticals Announces Hiring of Thomas E. Burke III as President and CEO
HSMN NewsFeed - 14 Nov 2007
FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
HSMN NewsFeed - 14 Nov 2007
New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
HSMN NewsFeed - 14 Nov 2007
VioQuest Appoints Michael D. Becker as President and Chief Executive Officer
VioQuest Appoints Michael D. Becker as President and Chief Executive Officer
HSMN NewsFeed - 14 Nov 2007
Biodel Inc. Announces Appointment of Gerard Michel as CFO, VP of Corporate Development and Treasurer
Biodel Inc. Announces Appointment of Gerard Michel as CFO, VP of Corporate Development and Treasurer
HSMN NewsFeed - 14 Nov 2007
OraSure Technologies and Schering-Plough to Settle Patent Infringement Litigation
OraSure Technologies and Schering-Plough to Settle Patent Infringement Litigation
HSMN NewsFeed - 14 Nov 2007
Study Shows Organon's Asenapine Demonstrates Efficacy and Tolerability in Treating Acute Schizophrenia
Study Shows Organon's Asenapine Demonstrates Efficacy and Tolerability in Treating Acute Schizophrenia
HSMN NewsFeed - 14 Nov 2007
Aspen Technology Appoints James Hintlian to Launch Pharmaceuticals Business Unit
Aspen Technology Appoints James Hintlian to Launch Pharmaceuticals Business Unit
HSMN NewsFeed - 14 Nov 2007
Kythera Biopharmaceuticals Appoints Industry Veteran as Vice President, Regulatory Affairs
Kythera Biopharmaceuticals Appoints Industry Veteran as Vice President, Regulatory Affairs
HSMN NewsFeed - 13 Nov 2007
Halozyme Therapeutics Names Matthew R. Hooper Vice President, General Counsel
Halozyme Therapeutics Names Matthew R. Hooper Vice President, General Counsel
HSMN NewsFeed - 13 Nov 2007
Introgen and Gendux Submit First Marketing Authorization Application for ADVEXIN
Introgen and Gendux Submit First Marketing Authorization Application for ADVEXIN
HSMN NewsFeed - 12 Nov 2007
VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement
VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement
HSMN NewsFeed - 12 Nov 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lamictal(R)
Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lamictal(R)
HSMN NewsFeed - 12 Nov 2007
AstraZeneca Appoints Kenneth L. Murtha as Regional Supply VP for the Americas
AstraZeneca Appoints Kenneth L. Murtha as Regional Supply VP for the Americas
HSMN NewsFeed - 12 Nov 2007
Verus Pharmaceuticals Announces Promotion of Robert W. Keith to Chief Executive Officer
Verus Pharmaceuticals Announces Promotion of Robert W. Keith to Chief Executive Officer
HSMN NewsFeed - 12 Nov 2007
FDA Accepts Chelsea Therapeutics' Investigational New Drug Application for Droxidopa
FDA Accepts Chelsea Therapeutics' Investigational New Drug Application for Droxidopa
HSMN NewsFeed - 12 Nov 2007
NicOx' naproxcinod phase 3 results presented at American College of Rheumatology
NicOx' naproxcinod phase 3 results presented at American College of Rheumatology
